Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 15, 2025

Primary Completion Date

December 15, 2030

Study Completion Date

January 15, 2032

Conditions
Locally Advanced Rectal Adenocarcinoma
Interventions
DRUG

FOLFOX4s

"6 cycles of FOLFOX4s intravenously: Oxaliplatin 85mg/m² over 2h, folinic acid 400mg/m2 (or L-folinic acid 200 mg/m2) over 2h, Fluorouracil bolus 400mg/m², Fluorouracil: 2400mg/m² over 46h, every 14 days for 12 weeks (max: 6 cycles). FOLFOX4 regimen will be started 2-4 weeks after completion of radiotherapy"

RADIATION

Short Course Radiotherapy

25Gy in 5 fractions of 5Gy delivered in one week (short-course radiotherapy)

All Listed Sponsors
lead

UNICANCER

OTHER